About Event

2nd Annual mRNA-Based Therapeutics Summit - What's On?

The mRNA industry has welcomed significant advancements in the next generation of mRNA vaccines and therapeutics with applications in indications beyond COVID-19 since the start of the pandemic. Now, the landscape for successful treatments seems limitless, and the future is brighter than ever for mRNA therapies. With the field’s substantial progress, we are excited to reveal the agenda for the 2nd Annual mRNA-Based Therapeutics Summit returning in person this July.

Access the official event guide to learn more.

What's New for 2022?

Attendees icon

350+ Attendees from Large Pharma, Biotech & Academia 

Speakers icon

75+ Thought Leading Speakers

arrows

5 Dedicated Tracks of Content Across 3 Days

Speakers icon

7+ Hours of Interactive Networking

cog

45+ Deep Dive Case Studies

Attendees icon

2 Biopharma Leaders Fireside Chats

Conference Overview

Pre-Conference Focus Day

ANALYTICAL DEVELOPMENT

  • Advance analytical methods and control strategies for mRNA vaccine and therapeutic development
  • Overcome potency, efficacy and biodistribution challenges of mRNA therapies with novel bioanalytical tools
  • Insights from: Arcturus Therapeutics, Sanofi, Merck & ReCode Therapeutics

SUPPLY CHAIN & LOGISTICS

  • Establish resilient supply chains and system management
  • Improve cold chain storage technologies for better drug product stability
  • Insights from: Beam Therapeutics, University of North Carolina at Charlotte, Center for Global Development & University of Orléans

Main Conference Days

DISCOVERY

  • Advance novel engineering approaches for next-generation mRNAs to expand therapeutic applicability
  • Achieve effective and targeted delivery for mRNA- based therapeutics 2.0
  • Insights from: Replicate Bioscience, Turn Biotechnologies, Capricor Therapeutics & Massachusetts Institute of Technology

PRE-CLINICAL & CLINICAL DEVELOPMENT

  • Supercharge the pre-clinical to clinical success of your mRNA-based therapeutics & vaccines
  • Unleash the power of mRNA technology for infectious and rare diseases, CAR-T therapies & beyond
  • Insights from: Moderna, Mercurna, Strand Therapeutics & Cartesian Therapeutics

MANUFACTURING

  • Trailblaze tech transfer and manufacturing for Phase 1 and beyond
  • Achieve consistency and sustainability with manufacturing at scale
  • Insights from: Ultragenyx, Verve Therapeutics, Tessera Therapeutics & King’s College London